Boothbay Fund Management »

Immunome shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $390k 18k 21.19

More positions owned by Boothbay Fund Management

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines Call Option (RVMD)
Ishares Tr Russell 2000 Etf Put Option (IWM)
Invesco Exch Traded Fd Tr Ii Kbw Bk Etf Call Option (KBWB)
Tesla Motors Call Option (TSLA)
Vaxcyte (PCVX)
Constellation Brands Cl A Call Option (STZ)
Apple Call Option (AAPL)
Advanced Micro Devices Call Option (AMD)
Cornerstone Strategic Value (CLM)
Liquidia Corporation Com New (LQDA)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)

View all positions for Boothbay Fund Management

Top funds holding Immunome

FMR
BlackRock
State Street Corporation
Wellington Management Company
Redmile Group
PRIMECAP Management Company
Vanguard Capital Management
Driehaus Capital Management
Enavate Sciences GP
T. Rowe Price Associates
Morgan Stanley
Geode Capital Management
Silverarc Capital Management
Jpmorgan Chase & Co
Sofinnova Ventures

View all funds holding Immunome